Concepts and challenges of biosimilars to mitigate the oncology drug expenses

Concepts and challenges of biosimilars to mitigate the oncology drug expenses

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dades bibliogràfiques
Autor principal:	Tania, Umme
Altres autors:	Haque , Md. Aminul
Format:	Thesis
Idioma:	en_US
Publicat:	Brac University 2021
Matèries:	Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise
Accés en línia:	http://hdl.handle.net/10361/15111

Ítems similars

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)

Biosimilar insulins: a potential option in the treatment of Diabetes
per: Tabassum, Turana
Publicat: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
per: Sagar, Baejid Hossain
Publicat: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
per: Fred, Namanda Rogers
Publicat: (2021)

A review on targeted therapies for lung cancer
per: Ashraf, Anushey
Publicat: (2023)

Osteoarthritis: a multi-disciplinary factual review
per: Subah, Nowshin
Publicat: (2021)

Biosimilars: A revolution for biologics in the pharmaceutical industry
per: Moreino, Shannon Sherwin
Publicat: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
per: Moya, Amena Khatun
Publicat: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
per: Chowdhury, Mashiat Nawar
Publicat: (2018)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
per: Choki, Kinley
Publicat: (2024)

Post Covid-19 health indications of Covid-19 patients
per: Khan, Tanzim
Publicat: (2022)

Recent advancement of biologics in Asthma
per: Evan, Al- Shahriar
Publicat: (2022)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
per: Lubaba, Anikah
Publicat: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
per: Ratu, Tabassum
Publicat: (2024)

A comprehensive review on drug repurposing in cancer treatment
per: Sarkar, Onusree
Publicat: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
per: Chakraborty, Anuradha
Publicat: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
per: Hoque, Syeda Mehren
Publicat: (2024)

Breast cancer therapy through Liposomal drug delivery system
per: Ome, Nusrat Jahan
Publicat: (2024)

An improved chromosome sorting algorithm by permutation group-based inverted block-interchanges
per: Tabassum, Afrida, et al.
Publicat: (2018)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
per: Akter, Anika
Publicat: (2022)

Risk of cancer associated with antihypertensive drugs
per: Iqbal, Adnan
Publicat: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
per: Rattry, Faria Rahman
Publicat: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
per: Hasan, Sakib
Publicat: (2024)

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
per: Dowla, Rumana, et al.
Publicat: (2022)

Biosimilars
Publicat: (2013)

Biosimilars

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
per: Razna, Amrin Islam
Publicat: (2019)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
per: Kamal, Tasnova
Publicat: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
per: Parvez, Safi
Publicat: (2023)

Sugar based biopolymers in nanomedicine: a review
per: Juthy, Afrin Rahman
Publicat: (2024)

A review on combinatorial therapies in Melanoma
per: Ahmmed, Md. Kawsar
Publicat: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
per: Hasan, Amit
Publicat: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
per: Nashrah, Zannatul
Publicat: (2023)

Food, nutrition, physical activity and the prevention of cancer : a global perspective : a project of World Cancer Research Fund International.
Publicat: (2007)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
per: Nahar, Kamrun
Publicat: (2023)